Rockwell Medical
RMTI | NASDAQ
$6.76
-$0.27 (-3.84%)
At close: Nov 16, 2026, 4:00 PM ET
$6.76
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
-3.84%
(1D)No price chart data available for 1D timeframe.
Rating
29.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #810/1021 (Top 79%)
Key Statistics
Market Data
Market Cap $27.25M
1D Range
6.66 6.97
52W Range
5.19 12.60
Valuation (TTM)
PE -4.57
PB 0.82
EV/EBITDA -7.52
Valuation (NTM)
Forward PE N/A
Forward PEG -0.15
Price Target $20.00
Cash Flow
FCF Yield 9.5%
SBC Adj. FCF Yield 3.2%
SBC Impact -66.7%
Margins
Gross Margin 18.1%
Operating Margin -7.1%
FCF Margin 3.6%
Growth (CAGR)
Revenue 3Y | 5Y -3.5% |
3.3%
Dil EPS 3Y | 5Y -42.5% |
78.2%
FCF 3Y | 5Y -2.8% |
94.9%
Returns
ROA -9.9%
ROE -16.0%
ROIC -11.1%
Financial Health
Net Cash
$13.49M
Current Ratio 2.47
Interest Coverage -4.56
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range o...
Sector Healthcare
Employees 157
IPO Date Jan 27, 1998
Website www.rockwellmed.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.59
Miss -227.78%
YoY:
-18.00% REV
$19.12M
Beat +4.95%
YoY:
+20.06%Next Earnings
Mar 25, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$20.00
Upside
+195.86%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove RMTI